Daclizumab for children with corticosteroid refractory graft-versus-host disease

[1]  E. Holler,et al.  Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept , 2005, Bone Marrow Transplantation.

[2]  D. Zahrieh,et al.  Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial. , 2004, Blood.

[3]  N. Geller,et al.  Improved survival in steroid‐refractory acute graft versus host disease after non‐myeloablative allogeneic transplantation using a daclizumab‐based strategy with comprehensive infection prophylaxis , 2004, British journal of haematology.

[4]  M. Pescovitz,et al.  Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporine and steroids in renal transplantation , 2003, Clinical transplantation.

[5]  J. Ferrara,et al.  The Pathophysiology of Acute Graft-versus-Host Disease , 2003, International journal of hematology.

[6]  A. Church.  Clinical advances in therapies targeting the interleukin-2 receptor. , 2003, QJM : monthly journal of the Association of Physicians.

[7]  A. Swiatecka-Urban.  Anti-Interleukin-2 Receptor Antibodies for the Prevention of Rejection in Pediatric Renal Transplant Patients , 2003, Paediatric drugs.

[8]  M. Kiehl,et al.  Treatment of steroid refractory acute and chronic graft‐versus‐host disease with daclizumab , 2001, British journal of haematology.

[9]  D. Kelly,et al.  Immunosuppressive Drugs in Paediatric Liver Transplantation , 2001, Paediatric drugs.

[10]  Pietra,et al.  Immunosuppression for pediatric cardiac transplantation in the modern era. , 2000, Progress in pediatric cardiology.

[11]  T. Starzl,et al.  The efficacy of daclizumab for intestinal transplantation: preliminary report. , 1999, Transplantation proceedings.

[12]  K. Cleary,et al.  Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. , 2000, Blood.

[13]  T. Waldmann,et al.  Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor. , 1994, Blood.